Volume 5, Issue 12: New Options for Patients with “Hard-To-Treat” Hepatitis C Infection

e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 5, Issue 12)

Target Audience

Nurses and health care professionals involved in the care of patients with Hepatitis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • Describe the appropriate use of the sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) regimen in retreatment of prior HCV treatment failures. 
  • Describe the appropriate use of the glecaprevir/pibrentasvir (GLE/PIB) regimen across HCV genotypes in treatment-naïve and treatment-experienced patients with or without cirrhosis. 
  • Describe the appropriate use of each of GLE/PIB in the treatment of HCV infection in patients with renal disease.
 
 

 

Additional information
Contact email: 
Course summary
Available credit: 
  • 0.50 ANCC
  • 0.50 Attendance
Course opens: 
01/25/2018
Course expires: 
01/24/2020
Cost:
$0.00
Ira M. Jacobson, MD
Director of Hepatology
New York University School of
Medicine
New York, NY
 
 

Available Credit

  • 0.50 ANCC
  • 0.50 Attendance

Accreditation Period

Course opens: 
01/25/2018
Course expires: 
01/24/2020

Price

Cost:
$0.00
Please login or register to take this course.

Click HERE to be directed to the DKB website. Select the desired article and proceed as instructed on the site. After completing the post-test and evaluation, DKB will award your certificate via email.